|1.||Kim, Sung Wan: 4 articles (10/2009 - 02/2003)|
|2.||Lee, Minhyung: 2 articles (01/2009 - 01/2005)|
|3.||Kim, S W: 2 articles (01/2009 - 09/2003)|
|4.||Bull, D A: 2 articles (01/2009 - 09/2003)|
|5.||Lee, M: 2 articles (01/2009 - 09/2003)|
|6.||Yockman, James W: 2 articles (01/2005 - 02/2003)|
|7.||Mahato, Ram I: 1 article (10/2009)|
|8.||Ye, Zhaoyang: 1 article (10/2009)|
|9.||Park, Hyung Chun: 1 article (01/2009)|
|10.||Kim, Kil Hwan: 1 article (01/2009)|
10/01/2009 - "This protocol describes the synthesis and characterization of water-soluble lipopolymer/lipopeptide-DNA complexes and their use in transfection of cultured cells and injection into tumor-bearing mice. "
02/21/2003 - "The objective of this work is to investigate the organ distribution and anti-tumor response in vivo after intratumoral administration of IL-12 expression plasmid complexed with water soluble lipopolymer (WSLP). "
01/03/2005 - "Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment."
09/01/2003 - "Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer."
01/05/2009 - "Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP)."
09/01/2003 - "To limit the risk of pathological angiogenesis, we developed a hypoxia-inducible VEGF gene therapy system using the erythropoietin (Epo) enhancer and water-soluble lipopolymer (WSLP). "
|4.||Myocardial Ischemia (Ischemic Heart Diseases)
|5.||Wounds and Injuries (Trauma)
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Interleukin-12 (IL 12)
|4.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|6.||DNA (Deoxyribonucleic Acid)
|1.||Drug Therapy (Chemotherapy)